05/05/2026
I’m excited to share that, together with Hui Fang and James Leiter, I was awarded an NIH R18 grant to advance a new platform for neurotransmitter sensing in the living human brain.
Many neurological and psychiatric diseases involve disruptions in brain chemistry, yet current clinical devices largely measure electrical activity alone. This project aims to help change that by translating recent advances in fast-scan cyclic voltammetry and carbon-coated neural sensors toward clinically deployable technology that can combine electrophysiology with real-time neurochemical sensing.
The work brings together an outstanding team across Dartmouth College, the WRJ VA Medical Center, Beth Israel Deaconess Medical Center, and NeuroOne Medical Technologies Corporation, with the goal of integrating neurotransmitter sensing capabilities into clinically used sEEG electrode platforms and laying the groundwork for first-in-human studies.
I’m grateful to the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke - NINDS for supporting this translational effort and excited for the opportunity to help move neurophysiological monitoring toward a future that captures both electrical and chemical dimensions of brain function.
